South Korea’s Hanmi Pharmaceutical is betting on big growth from its newly minted $140 million smart drug manufacturing facility as the company moves toward becoming a player in the CDMO market. The ...

The hearing for the injunction request to prohibit the issuance of new shares filed by brothers Lim Jong-yoon and Lim Jong-hoon of Hanmi, which will determine the success of the merger between Hanmi ...

The call-off came on Thursday as the eldest son of the controlling family behind Hanmi and his allies emerged as the winner of the family feud against his sister and mother during the pharmaceutical ...

The management conflict within the founding family of Hanmi Pharmaceutical Group ended, as the sons of founder Lim Sung-ki -- Lim Jong-yoon and Lim Jong-hoon -- secured a majority within Hanmi Science ...

Hanmi Science, the holding company of Hanmi Pharmaceutical Group, approved the dismissal of Song Yeong-sook, the wife of the company’s founder, the late Lim Sung-ki, from the CEO position, at an ...

The Hanmi Pharmaceutical Group chairwoman and her daughter, who seek to merge the drug developer with OCI Group, a local chemical company, were neck and neck with their opponents, led by the ...